Cleared Traditional

K251972 - Healgen® AccuFluor Fentanyl Fluorescence Immunoassay (FIA)Test Kit - Qualitative (FDA 510(k) Clearance)

Also includes:
Healgen® Immunofluorescence Analyzer (OG-H180)
Aug 2025
Decision
50d
Days
Class 2
Risk

K251972 is an FDA 510(k) clearance for the Healgen® AccuFluor Fentanyl Fluorescence Immunoassay (FIA)Test Kit - Qualitative. This device is classified as a Enzyme Immunoassay, Opiates (Class II - Special Controls, product code DJG).

Submitted by Healgen Scientific, LLC (Houston, US). The FDA issued a Cleared decision on August 15, 2025, 50 days after receiving the submission on June 26, 2025.

This device falls under the Toxicology FDA review panel. Regulated under 21 CFR 862.3650.

Submission Details

510(k) Number K251972 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 26, 2025
Decision Date August 15, 2025
Days to Decision 50 days
Submission Type Traditional
Review Panel Toxicology (TX)
Summary Summary PDF

Device Classification

Product Code DJG — Enzyme Immunoassay, Opiates
Device Class Class II - Special Controls
CFR Regulation 21 CFR 862.3650

Similar Devices — DJG Enzyme Immunoassay, Opiates

All 23
Labcorp Fentanyl Urine Visual Test
K252684 · Medtox Diagnostics, Inc. · Jan 2026
LZI Buprenorphine II Enzyme Immunoassay
K253082 · Lin-Zhi International, Inc. · Jan 2026
SEFRIA™ Hydrocodone Oral Fluid
K252520 · Immunalysis Corporation · Sep 2025
LZI Fentanyl III Enzyme Immunoassay
K251634 · Lin-Zhi International, Inc. · Jun 2025
CEDIA Heroin Metabolite (6-AM) Assay
K231007 · Microgenics Corporation · Sep 2023
Emit® II Plus Buprenorphine Assay
K221605 · Siemens Healthcare Diagnostics, Inc. · Jul 2023